Financials Cabot Corporation

Equities

CBT

US1270551013

Specialty Chemicals

Market Closed - Nyse 04:00:02 2024-04-26 pm EDT 5-day change 1st Jan Change
93.59 USD +0.60% Intraday chart for Cabot Corporation +1.72% +12.08%

Valuation

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,619 2,034 2,843 3,597 3,875 5,188 - -
Enterprise Value (EV) 1 3,514 2,998 3,837 4,834 4,913 6,177 6,108 6,071
P/E ratio 17.2 x -8.56 x 11.5 x - - - - -
Yield 3% 3.89% 2.79% 2.32% 2.22% 1.75% 1.88% 1.99%
Capitalization / Revenue 0.78 x 0.78 x 0.83 x 0.83 x 0.99 x 1.28 x 1.21 x 1.16 x
EV / Revenue 1.05 x 1.15 x 1.13 x 1.12 x 1.25 x 1.53 x 1.42 x 1.36 x
EV / EBITDA 6.49 x 7.51 x 5.88 x 6.64 x 7.07 x 7.65 x 6.93 x 6.69 x
EV / FCF 25.6 x 16.9 x 61.9 x -43.5 x 14 x 17.7 x 31.4 x 28.4 x
FCF Yield 3.9% 5.9% 1.62% -2.3% 7.14% 5.65% 3.18% 3.52%
Price to Book 2.59 x 2.94 x 3 x 4.02 x - 3.59 x 3.11 x 2.74 x
Nbr of stocks (in thousands) 57,783 56,462 56,724 56,299 55,937 55,431 - -
Reference price 2 45.32 36.03 50.12 63.89 69.27 93.59 93.59 93.59
Announcement Date 11/4/19 11/23/20 11/8/21 11/7/22 11/6/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,337 2,614 3,409 4,321 3,931 4,042 4,293 4,453
EBITDA 1 541 399 652 728 695 807.8 881.8 907.3
EBIT 1 394 242 492 583 553 655.2 723.1 770.5
Operating Margin 11.81% 9.26% 14.43% 13.49% 14.07% 16.21% 16.84% 17.3%
Earnings before Tax (EBT) 1 255 -33 406 335 451 534.7 611.5 677
Net income 157 -238 250 209 445 - - -
Net margin 4.7% -9.1% 7.33% 4.84% 11.32% - - -
EPS 2.630 -4.210 4.340 - - - - -
Free Cash Flow 1 137 177 62 -111 351 349 194.5 214
FCF margin 4.11% 6.77% 1.82% -2.57% 8.93% 8.63% 4.53% 4.81%
FCF Conversion (EBITDA) 25.32% 44.36% 9.51% - 50.5% 43.2% 22.06% 23.59%
FCF Conversion (Net income) 87.26% - 24.8% - 78.88% - - -
Dividend per Share 2 1.360 1.400 1.400 1.480 1.540 1.641 1.757 1.861
Announcement Date 11/4/19 11/23/20 11/8/21 11/7/22 11/6/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 904 968 1,092 1,149 1,112 965 1,033 968 965 958 1,045 1,024 1,008 1,014 1,167
EBITDA 1 143 162 191 197 178 142 170 189 194 181 198.1 203.2 203.1 200.2 233.9
EBIT 1 101 123 155 162 143 108 134 153 158 140 160.6 165 164.9 161.2 194.9
Operating Margin 11.17% 12.71% 14.19% 14.1% 12.86% 11.19% 12.97% 15.81% 16.37% 14.61% 15.37% 16.12% 16.36% 15.9% 16.71%
Earnings before Tax (EBT) 1 66 -93 147 152 129 84 110 130 127 - 137.3 132.6 140.8 - -
Net income 29 -89 107 97 94 54 75 82 234 - - - - - -
Net margin 3.21% -9.19% 9.8% 8.44% 8.45% 5.6% 7.26% 8.47% 24.25% - - - - - -
EPS 0.5000 -1.570 1.840 - - 0.9300 1.290 1.430 - - - - - - -
Dividend per Share 2 0.3500 0.3700 0.3700 0.3700 0.3700 0.3700 - 0.4000 - - 0.3943 0.3943 0.4337 0.4337 0.4337
Announcement Date 11/8/21 1/31/22 5/2/22 8/8/22 11/7/22 2/9/23 5/8/23 8/7/23 11/6/23 2/5/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 895 964 994 1,237 1,038 989 920 883
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.654 x 2.416 x 1.525 x 1.699 x 1.494 x 1.224 x 1.043 x 0.9735 x
Free Cash Flow 1 137 177 62 -111 351 349 195 214
ROE (net income / shareholders' equity) 21.4% 13.9% 34.8% 39% 28.1% 27.2% 26.7% 25.8%
ROA (Net income/ Total Assets) 7.36% 4.07% 9.37% 10.5% 8.53% 9.92% 10.5% 10.9%
Assets 2,133 -5,848 2,668 1,983 5,218 - - -
Book Value Per Share 2 17.50 12.20 16.70 15.90 - 26.10 30.10 34.20
Cash Flow per Share 2 6.140 6.660 4.520 1.760 10.50 9.120 9.880 10.30
Capex 1 224 200 195 211 244 255 285 294
Capex / Sales 6.71% 7.65% 5.72% 4.88% 6.21% 6.31% 6.64% 6.6%
Announcement Date 11/4/19 11/23/20 11/8/21 11/7/22 11/6/23 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
93.59 USD
Average target price
95.33 USD
Spread / Average Target
+1.86%
Consensus
  1. Stock Market
  2. Equities
  3. CBT Stock
  4. Financials Cabot Corporation